Skip to main content
JEIL PHARMA HOLDINGS INC. logo

JEIL PHARMA HOLDINGS INC. — Investor Relations & Filings

Ticker · 002620 ISIN · KR7002620003 KO Manufacturing
Open in API
Filings indexed 112 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 002620

About JEIL PHARMA HOLDINGS INC.

https://www.jeilpharm.co.kr/english/

Jeil Pharma Holdings Inc., established in 1959, is a pharmaceutical company engaged in the development, manufacturing, and distribution of medical products. The company's portfolio includes finished pharmaceutical products, active pharmaceutical ingredients (APIs), incrementally modified drugs, and generic drugs. Key product categories include analgesic anti-inflammatories and broad-spectrum oral medications. The company is also focused on developing high-value products and aims to be a leading manufacturer of injection medicines.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Regulatory Filings
2026-04-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회결과” and contains the voting outcomes for each agenda item (approval of financial statements, election of directors, changes to articles, etc.) at the regular shareholders’ meeting. It reports the percentages of votes for and against, dividend resolutions, and appointment details. This matches the definition of a “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA).
2026-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a Korean disclosure titled “사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고,” detailing the appointment/reappointment of an outside (independent) director, including dates and term information. It is addressed to the Financial Services Commission/Korea Exchange and describes changes in board composition. This matches the Board/Management Information category (announcement of changes in the company’s board of directors).
2026-03-24 Korean
사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a comprehensive 'Business Report' (사업보고서) for Jeil Pharma Holdings, covering the 66th fiscal year (2025). It contains detailed sections on company overview, business operations, financial statements (audited), management discussion and analysis, and governance. This structure matches the standard requirements for an Annual Report (10-K equivalent in the Korean market). FY 2025
2026-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Jeil Pharma Holdings. It contains the auditor's opinion, financial statements (consolidated and separate), and key financial metrics for the fiscal year. While it provides financial data, it is a specific regulatory filing regarding the submission of the audit report to the exchange, rather than the full Annual Report (10-K) itself. According to the classification rules, this fits the 'Audit Report / Information' (AR) category as it is a standalone report of audit results. FY 2025
2026-03-16 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Jeil Pharma Holdings. It contains the agenda for the meeting, including the approval of financial statements, election of directors, and dividend proposals. While it contains financial data (financial statements), this data is provided as part of the meeting materials for shareholders to review prior to the vote, rather than being the standalone Annual Report (10-K) or an Earnings Release. According to the filing definitions, materials shared for an AGM are classified as AGM-R.
2026-03-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.